1. Home
  2. KNSA vs NYAX Comparison

KNSA vs NYAX Comparison

Compare KNSA & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • NYAX
  • Stock Information
  • Founded
  • KNSA 2015
  • NYAX 2005
  • Country
  • KNSA United Kingdom
  • NYAX Israel
  • Employees
  • KNSA N/A
  • NYAX N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • NYAX
  • Sector
  • KNSA Health Care
  • NYAX
  • Exchange
  • KNSA Nasdaq
  • NYAX Nasdaq
  • Market Cap
  • KNSA 2.1B
  • NYAX 1.7B
  • IPO Year
  • KNSA 2018
  • NYAX N/A
  • Fundamental
  • Price
  • KNSA $27.53
  • NYAX $50.27
  • Analyst Decision
  • KNSA Strong Buy
  • NYAX Buy
  • Analyst Count
  • KNSA 5
  • NYAX 6
  • Target Price
  • KNSA $38.80
  • NYAX $38.33
  • AVG Volume (30 Days)
  • KNSA 1.1M
  • NYAX 24.5K
  • Earning Date
  • KNSA 07-22-2025
  • NYAX 08-06-2025
  • Dividend Yield
  • KNSA N/A
  • NYAX N/A
  • EPS Growth
  • KNSA N/A
  • NYAX N/A
  • EPS
  • KNSA N/A
  • NYAX 0.18
  • Revenue
  • KNSA $481,166,000.00
  • NYAX $331,161,000.00
  • Revenue This Year
  • KNSA $37.21
  • NYAX $33.44
  • Revenue Next Year
  • KNSA $5.32
  • NYAX $23.74
  • P/E Ratio
  • KNSA N/A
  • NYAX $283.53
  • Revenue Growth
  • KNSA 59.45
  • NYAX 34.05
  • 52 Week Low
  • KNSA $17.38
  • NYAX $20.31
  • 52 Week High
  • KNSA $30.69
  • NYAX $50.27
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 54.29
  • NYAX 68.10
  • Support Level
  • KNSA $27.62
  • NYAX $48.08
  • Resistance Level
  • KNSA $29.23
  • NYAX $49.85
  • Average True Range (ATR)
  • KNSA 1.03
  • NYAX 1.08
  • MACD
  • KNSA -0.21
  • NYAX 0.38
  • Stochastic Oscillator
  • KNSA 46.99
  • NYAX 97.67

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

Share on Social Networks: